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ABSTRACT
THE RELATIONSHIP BETWEEN ENTERAL NUTRITION FORMULA
COMPOSITION, FEEDING TUBE PLACEMENT SITE, AND THE START OF
ENTERAL FEEDINGS ON THE DEVELOPMENT OF VENTILATOR ASSOCIATED
EVENT IN AN ADULT INTENSIVE CARE UNIT
by
Jessica M. Alexander
Background: Ventilator associated pneumonia (VAP) is a major cause of morbidity,
longer intensive care unit (ICU) stay, increased duration of mechanical ventilation, and
increased healthcare cost in critically ill patients. Critically ill patients are at increased
risk for malnutrition, which is associated with impaired immune function, impaired
ventilator drive and weakened respiratory muscles. Malnutrition has been thought to
increase the risk of VAP due to bacterial translocation from the gastrointestinal tract to
the lungs. Previous research that has evaluated the effect of enteral nutrition on
malnutrition associated with VAP has been inconsistent in part because of the
subjectivity of the old definition of VAP. In 2013, the Center for Disease Control and
Prevention (CDC) developed a new definition for the diagnosis of VAP, which includes
three tiers of a ventilator associated event (VAE); ventilator associated condition,
infection-related ventilator-associated complication, or possible or probable VAP). The
purpose of this study is to retrospectively examine the relationship between enteral
formula, tube-feeding placement site, time of tube feeding initiation and the incidence of
VAE using this new CDC definition.

	
  

	
  
Objective: The aim of the study was to retrospectively examine the relationship between
enteral formula, tube-feeding placement site, time of tube feeding initiation and the
incidence of VAE using this new CDC definition.
Participants/setting: The medical records of 162 adult patients admitted to one of the
ICUs (Medical ICU, Surgical ICU, Neurological ICU, Burn ICU) at Grady Memorial
Hospital (GMH) in Atlanta, GA in 2013
Main outcome measures: Demographic and baseline medical characteristics including
the type of enteral formula used (standard, immune-modulating, hydrolyzed, immunemodulating and hydrolyzed, or mixed), enteral tube feeding placement (gastric or small
bowel), and timing of enteral nutrition (never fed, fed <48 hours after admission or fed
>48 hours after admission) were collected.
Statistical analysis: Demographic and baseline medical characteristics were described
using frequency statistics and compared by VAE status using the Mann-Whitney U and
Kruskal-Wallis tests. The relationship between tube placement, enteral formula, timing of
feeding and the diagnosis of a VAE was evaluated using the Chi-square test.
Results: In 2013, 81 patients admitted to the ICU at GMH were diagnosed with a VAE.
The median age of the study population (n=162) was 50 years (range, 19 to 88 years) and
the median BMI was 27.6 kg/m2 (range, 13.2 to 83.2 kg/m2). The majority of the
population was African American (53.1%) and male (64.2%). Most patients were fed
through a gastric tube (86.4%), were given an immune-modulating enteral formula
(32.1%) and were fed after 48 hours of admission (44.4%). After subdividing by ICU
location, 12 of 14 patients (86%) in the Medical ICU who were diagnosed with a VAE
were either never fed or fed >48 hours after admission vs. 7 of 13 (54%) of patients in the

	
  

	
  
Medical ICU who were not diagnosed with a VAE (p=0.031). No other relationships
between the type of feeding initiation, tube placement, and enteral formula were found by
VAE status for the population or by ICU location.
Conclusion: Adults admitted to the Medical ICU may have a reduced risk of developing
a VAE if fed within 48 hours of admission. The type of enteral formula provided and the
route of administration was not associated with the diagnosis of VAE. Future prospective
studies should include all critical care patients to further evaluate the effect of nutrition
on VAE outcome.
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CHAPTER I
THE RELATIONSHIPS AMONG ENTERAL NUTRITION FORMULA
COMPOSITION, FEEDING TUBE PLACEMENT SITE, AND THE START OF
ENTERAL FEEDINGS ON THE DEVELOPMENT OF A
VENTILATOR ASSOCIATED EVENT IN AN ADULT INTENSIVE CARE UNIT

Introduction
Ventilator associated pneumonia (VAP) is a major cause of morbidity, longer
intensive care unit (ICU) stay, increased duration of mechanical ventilation, and
increased healthcare cost in critically ill patients.1 Critically ill patients are at increased
risk for malnutrition because of stress hyper-metabolism.2 Malnutrition is associated with
impaired immune function, impaired ventilator drive, and weakened respiratory muscles,
leading to prolonged ventilator dependence and increased infectious morbidity and
mortality.3,4 Malnutrition is thought to increase the risk for VAP through bacterial
translocation from the gastrointestinal tract to the lungs.2 It is important to feed critically
ill patients whenever medically possible to avoid the development of malnutrition.
However, this does not always happen quickly or efficiently due to the perceived fears of
complications associated with enteral feeding.
The effect of enteral nutrition on malnutrition associated with VAP has been
researched for many years but the literature remains inconsistent. Reasons include
subjectivity and complexity of the old definition of VAP (used until 2013), lack of
documentation between facilities, and pressure on physicians to have lower reported
1	
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incidences of VAP. The Centers for Disease Control and Prevention (CDC) recently
developed a new definition of VAP in an attempt to address some of these issues. The
new definition for diagnosis uses a combination of objective criteria and recordable data
that helps in getting close to a standardized VAP definition. VAP prevention as a national
patient safety goal has been proposed as one of the conditions that is non-reimbursable by
Medicare and Medicaid1, which intensifies the pressure on physicians to have lower
incidences of VAP. The subjective nature of the previous definition of VAP caused large
variation in diagnosis from physician to physician as well as study to study.1 Thus, the
CDC released the Ventilator Associated Event (VAE) surveillance definition in January
2013, which is based on an objective, streamlined, and potentially automatable criteria.
There are three definition tiers with the VAE definition: 1) Ventilator-Associated
Condition (VAC), 2) Infection- related Ventilator-Associated Complication (IVAC), and
3) Possible and Probable VAP. These different tiers build upon one another, but all VAEs
are identified by using a combination of objective criteria: deterioration in respiratory
status after period of stability or improvement on the ventilator, evidence of infection, or
inflammation and laboratory evidence of respiratory infection.5 In order to determine the
validity of the current evidence, objective measures need to be used in future research.
There is a lack of literature on the relationship between the use of enteral feedings and
VAE. The literature evaluating feeding tube placement site and VAP incidence is
inconsistent and there are no studies examining VAE incidence. Moreover, the
relationship between the start of enteral feeding and VAP requires reexamination using
the new CDC definition of VAE.
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A study was conducted at Grady Memorial Hospital (Grady) in Atlanta, Georgia
to retrospectively examine the relationship between type of enteral formula, tube-feeding
placement site, time of tube feeding initiation (within 48 hours vs. after 48 hours) and the
incidence of VAE. Grady is a Level 1 trauma center with five adult intensive care units.
Outcome Data Collectors at Grady have been using the new CDC definition of VAE
since January, 2013. The research hypotheses of the study were:
1. Patients who received enteral tube feedings within 48 hours of admission will
have lower rates of VAE than patients who either received feedings after 48
hours or did not receive any enteral feedings.
2. Patients who receive Impact®, an immune-modulating formula, will have a
lower incidence of VAE than patients receiving other formulas.
3. Patients who have a nasojejunal tube for enteral feeding will have lower
incidence of VAE compared to patients with a feeding nasogastric tube.

	
  

	
  

CHAPTER II
Literature Review
From 1975 to 1985 the CDC conducted a nationwide study to examine if hospital
acquired infections could be reduced through control programs. The CDC determined
that four components of surveillance were needed: 1) feedback of infection control rates
to hospital staff; 2) enforcement of preventative practices; 3) a supervising infection
preventionist to collect and analyze surveillance data; and 4) the involvement of a
physician or microbiologist with specialized training in infection prevention and control.6
This was the beginning of the CDC recognizing a need for a VAP definition and an
outline for the different components necessary to survey and diagnose the infection. In
1988 the National Nosocomial Infection Survey (NNIS) defined two pneumonia criteria
for adults that included clinical findings with the results of laboratory tests but did not
include chest x-rays.7,8 In 2002, the new NNIS pneumonia definitions were implemented,
which required chest x-ray evidence.7 The new CDC surveillance definition uses a
combination of objective criteria: deterioration in respiratory status after a period of
stability or improvement on the ventilator, evidence of infection or inflammation, and
laboratory evidence of respiratory infection.8

Enteral Feeding Tube Placement
Four studies have examined the relationship between transpyloric feeding tube
placement and the incidence of VAP. The study by Acosta-Escribano et al. (2010)
compared nasogastric (NG) feeding tube to nasojejunal (NJ) feeding tube in patients with
4	
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traumatic brain injuries.9 A total of 104 patients were randomized into either NG (n= 54)
or NJ (n= 50) tube-feeding placement and were fed the same formula as a continuous
feeding. Pneumonia was determined using the clinical pulmonary infection score (CPIS)
criteria with a score higher than 6 indicating pneumonia. Almost half (n=47) of the
patients developed VAP, 16 in the NJ group compared with 31 in the NG group (p
<0.01). Patients with traumatic brain injuries had decreased incidence of VAP when fed
through a transpyloric feeding tube than when fed through a nasogastric feeding tube.
Hsu et al. (2009) compared nasoduodenal (ND) and NG feeding tubes in critically ill
patients.10 A total of 121 patients were randomized to ND (n=59) and NG (n=62)
feedings. In this study, VAP diagnosis required the agreement of two third-party
pulmonologists reviewing radiographs using the CDC criteria. Fifteen patients (24.2%) in
the NG group compared with 5 (8.5%) patients in the ND group developed VAP (p=
0.02). Patients in the medical ICU who were fed via an ND tube had lower incidence of
VAP and better outcomes than those fed with NG tubes. Davies et al. (2012) also
compared NJ and NG feedings in mechanically ventilated critically ill adults with
elevated gastric residual volumes (GRV) within 72 hours of admission to the ICU.11 A
total of 180 patients were included in the study. Initially patients were fed through an
NG tube, then they were randomized to either NJ feedings (n=91) or to remain on NG
feedings (n=89). An intention to treat analysis was used. Twelve patients randomized to
the NJ group could not receive the feeding, as the tube did not pass beyond the stomach.
In addition, eight patients assigned to the NG group were switched to an NJ feeding tube
due to enteral nutrition intolerance. If the development of VAP was suspected, additional
data were collected and provided to an adjudication panel. The diagnosis of VAP was
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confirmed if at least two of the three adjudicators met the diagnosis of VAP. Eighteen
patients in the NJ group and 19 patients in the NG group developed VAP (p = 0.94).
Switching patients to a NJ feeding tube after they exhibited delayed gastric emptying did
not significantly decrease the incidence of VAP.
White et al. (2009) compared NG and post-pyloric feedings in critically ill
patients.12 A total of 104 patients were randomized with 54 in the NG group and 50 in the
post-pyloric group. Four patients originally randomized to NG feeding received a postpyloric tube due to increased GRV. Ten patients randomized to post-pyloric feeding
received a NG tube due to unsuccessful placement of the post-pyloric tube. VAP was
diagnosed using a CPIS score greater than 6 and the presence of fever, leukocytosis,
pulmonary secretions, as well as radiographic imaging. Under the intent to treat analysis,
VAP was diagnosed in five patients in the post-pyloric group and eleven in the
nasogastric group (p=0.18). Treating patients with early post-pyloric tubes did not
significantly decrease the incidence of VAP compared to early NG tubes.
These studies used varying diagnosis of VAP and had high subjectivity toward the
diagnosis due to the inter-observer variability.1 Radiography as a tool for VAP diagnosis
has been highly criticized because interpretation is subjective. The new definition
removes this subjectivity by eliminating the radiographic imaging as part of the
diagnostic criterion. Furthermore, the results of these studies indicate that the relationship
between tube-feeding placement site and the incidence of VAP is still unknown.
Enteral Nutrition Formula and Timing of Implementation
Very few studies have examined the effect of different enteral adult formulas on
the incidence of VAP. Caparros et al. (2001) compared the effect of providing a high-
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protein enteral nutrition formula with supplemental arginine, fiber, and antioxidants to a
standard high-protein formula on overall nosocomial infection rates in critically ill
patients.13 The researchers did not specifically analyze data for the presence of VAP.
Nevertheless, this study did not find a significant relationship between the type of
formula used and rates of nosocomial infections (p= 0.3).
In a retrospective study Artinian et al. (2006) examined the effects of nutrition
timing on VAP incidence in critically ill patients.14 Early feeding was defined as feeding
within the first 48 hours of mechanical ventilation with patients who were ventilated for
more than 2 days. VAP diagnosis was defined as new or progressive infiltrate,
consolidation, cavitation, or pleural effusion of new onset of purulent sputum or change
in character of sputum, organism isolated from blood culture, isolation of pathogen from
specimen obtained by tracheal aspirate, bronchial brushing or biopsy, or histopathologic
diagnosis of pneumonia.14 A total of 2,537 patients had been fed early and 1,512 were
identified as having received later feedings. After controlling for baseline differences,
early feeding was associated with a higher risk of VAP development. In the early feeding
group, 284 patients were diagnosed with VAP compared to 143 in the later feeding group
(p=0.08). Feeding tube placement was not collected in this patient population and thus
could not be analyzed. It cannot be ruled out that there may have been a significant
difference between early and late feeding groups and tube placement. This tube
placement could have had an effect on VAP.

	
  

	
  

CHAPTER III
Methods
We conducted a retrospective review of medical records of patients admitted to
the ICU at Grady Memorial Hospital in Atlanta, GA during 2013. There are five ICUs at
Grady including two Surgical ICUs (SICUs), a Medical ICU (MICU), a Neurosurgical
ICU (NICU), and a Burn ICU (BICU). Patients admitted to the SICU were greater than
18 years old and had life threatening injuries that required immediate surgical
intervention. Patients admitted to the MICU were greater than 18 years old whose
admitting diagnoses included organ failure, sepsis, or gastrointestinal bleeding. Patients
with life threatening neurological issues such as status epilepticus, hemorrhagic or
ischemic strokes were admitted to the NICU. Admissions to the BICU included both
pediatric and adult patients who had sustained life-threatening burns to their skin as well
as smoke inhalation injuries.
Patients who received mechanical ventilation for more than 48 hours were
included in the study. Exclusion criteria included patients below the age of 18 years,
previous anatomy altering upper gastrointestinal surgery, bowel obstruction, pregnancy,
presence of a gastrostomy or jejunostomy tube on admission, death within 48 hours, and
intubation >24 hours after admission. Patients who developed a VAE were identified
using a VAE registry maintained by Grady Memorial Hospital infection preventionist. An
equal number of patients, matched by ICU admission, who were not diagnosed with a
VAE were randomly selected for comparison. All patient identifiers (name, birthdate,

8	
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medical record number, social security number) were removed and an individual patient
identifier was assigned to protect patient privacy. The medical records were reviewed for
demographic and baseline medical characteristics, including, diagnosis of VAE,
admitting diagnosis, specific enteral feeding tube placement (gastric tube placement or
small bowel tube placement), the timing of enteral nutrition (before or after 48 hours of
admission, or never fed enterally), and type of enteral formula used (standard formula or
immune-modulating formula or hydrolyzed formula or immune-modulating and
hydrolyzed formula or mixed formula).
Standard enteral formulas such as Isosource®, Novasource®, and Jevity® are
most commonly used to feed patients and contain intact proteins, carbohydrates, long
chain triglycerides, and vitamins and minerals; some contain fiber. The formulas used in
this population were Isosource®, Novasource®, Jevity® and Suplena® which is a low
protein product with lower nutrient content of some vitamins and minerals. Immune
modulating formulas contain one or more nutrients beyond the standard macro- and
micronutrients. These additional nutrients could include arginine, glutamine, omega 3
fatty acids, antioxidants, gamma linoleic acid, nucleotides, and antioxidants.9 The
immune-modulating formulas used in this population were Impact® and Oxepa®.
Hydrolyzed formula is a peptide-based formula that contains 100% enzymatically
hydrolyzed (elemental) whey protein.10 The hydrolyzed formula used in this population is
Peptamen® and Peptamen Bariatric®. The immune-modulating, hydrolyzed formula
contains hydrolyzed casein protein, arginine, glutamine, omega-3 fatty acids and
nucleotides.11 The immune-modulating, hydrolyzed formula used in this population was
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Impact Peptide®. For the purposes of this study, any patient that received more than one
category of formula were analyzed as receiving a mixed formula.
Data were recorded onto a source document and subsequently entered into a
Microsoft Excel database. Demographic and baseline characteristics, feeding tube
placement, and early versus late feedings were described using frequency statistics.
Variables were compared by VAE status using the Mann- Whitney U test and KruskalWallis analysis of variance by ranks as the data were not normally distributed even after
log transformation. The difference in type of tube placement (Gastric vs. Small bowel),
the type of enteral formula, the initiation of feeding and the incidence of VAE were
evaluated using a Chi-square test. Data were analyzed as a total population of ICU
patients and by ICU location as the severity of illness varies among the units. All
statistical analyses were conducted using SPSS (version 20.0, SPSS, Inc., Chicago, IL).
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Results
In 2013, eighty-one patients admitted to the ICU at GMH were diagnosed with a
VAE. The comparison group included 81 patients who had not been diagnosed with a
VAE. The median age of the study population (n=162) was 50 years (range, 19 to 88
years) and the median admitting body mass index (BMI) was 27.6 kg/m2 (range, 13.2 to
83.2 kg/m2) (Table 1). Patients BMI were analyzed because previous studies have shown
that a higher BMI increases the risk for infection. The majority of the population was
African American (53.1%) and male (64.2%). The age of patients differed by ICU
admission status (Table 2). However, no significant difference in anthropometric status
was observed by ICU location. No significant differences in demographic or
anthropometric characteristics were observed by VAE status (Table 3).

11	
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Table 1. Demographic and anthropometric characteristics of the total population
Characteristics

Total Population
(n=162)

Age (years)a

50 (34.75, 63.25)

Gender (%)
Male

64.2

Female

35.8

Race (%)
African American

53.1

Caucasian

34.6

Hispanic

4.3

Asian

1.9

American Indian

0.6

Multiracial

0.6

Unknown

4.9

Height (m)a

1.727 (1.65, 1.80)

Weight (kg)a

82 (70, 98.2)

BMI (kg/m2)a

27.67 (23.9, 32.6)

a

Median (25%, 75%)

BMI - Body Mass Index, y – years, m – meters, kg – kilograms
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Table 2. Demographic and anthropometric characteristics of the population by intensive
care unit (ICU)
Characteristica

Neuro ICU

Burn ICU

Surgical ICU

Medical ICU

(n = 32)

(n = 22)

(n = 80)

(n = 28)

57

55

43.50

53

(45, 66)

(35, 64)

(26, 57)

(43, 64)

1.7

1.75

1.75

1.71

(1.63, 1.77)

(1.7, 1.8)

(1.65, 1.8)

(1.62, 1.77)

83.9

80

81

81.3

(70.25, 100.52)

(74.9, 98.1)

(70, 92.2)

(68.2, 103)

30.1

27.1

26.9

26.8

(23.9, 30)

(24.2, 30.9)

(23.9, 32.1)

(23.3, 36.4)

Age (y)

Height (m)

Weight (kg)

BMI (kg/m2)

a

P-value

0.001

0.145

0.764

0.448

Median (25%, 75%)

ICU – intensive care unit, BMI – body mass index, y – years, m – meters, kg – kilograms
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Table 3. Demographic and anthropometric characteristics by VAE status
Characteristicsa

VAE

NON-VAE

(n = 81)

(n = 81)

49 (32, 64)

51 (35, 63)

0.482

Height (m)

1.727 (1.65, .80)

1.727 (1.63, 1.80)

0.691

Weight (kg)

83.9 (70.5, 100)

80 (70, 90)

0.434

BMI (kg/m2)

27.67 (24.0, 32.8)

27.38 (23.52, 32.17)

0.950

Age (y)

a

P-value

Median (25%, 75%)

VAE - ventilator associated event; BMI – body mass index, y – years, m - meters, kg –
kilograms
The enteral feeding characteristics of the population are shown in Table 4. Most
patients were fed through a gastric tube (86.4%), were given an immune-modulating
enteral formula (32.1%), and were fed after 48 hours of admission (44.4%). The feeding
tube placement, enteral formula, and time to feeding initiation characteristics by ICU
status are shown in Table 5. The majority of patients in the BICU, SICU, and MICU who
received a feeding tube and all NICU patients requiring enteral nutrition support were fed
via gastric tube. Most of the patients fed through a small bowel tube were in the SICU.
Providers in the NICU and MICU prescribed standard enteral formula for the majority of
their patients. The SICU providers prescribed an immune-modulating formula more
frequently while the BICU providers prescribed an immune-modulating, hydrolyzed
formula more frequently. Dietitians at GMH refer to the American Society of Parenteral
and Enteral Nutrition/ Society of Critical Care Medicine’s guidelines for the provision
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and assessment of nutrition support therapy in the adult critical ill patient when making
recommendations for nutrition support in critically ill patients, which may be the reason
why an immune-modulating formula was used more frequently. The majority of patients
admitted to the NICU and BICU were fed within 48 hours of admission (71.9% and
36.4%, respectively) while most of the patients in the SICU and MICU were fed after 48
hours (55% and 50%, respectively).
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Table 4. Enteral feeding characteristics of the total ICU population
Characteristics

Total Population
(n = 162)

Feeding Tube Placement (%)
Gastric

86.4

Small bowel

5.6

Unknown

8.0

Enteral Formula (%)
Standard

27.8

Immune-modulating

32.1

Hydrolyzed

3.1

Immune-modulating, hydrolyzed

11.7

Mixed formula

8.0

Unknown

17.3

Initiation of Feeding (%)
Before 48 hours

30.9

After 48 hours

44.4

Never fed enterally

22.2

Unknown

2.5

ICU – intensive care unit
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Table 5. Enteral feeding characteristics of the population by ICU admission status
Neuro

Burn

Surgical

Medical

ICU

ICU

ICU

ICU

(n = 32)

(n = 22)

(n=80)

(n=28)

100

95.5

78.8

85.7

Small bowel

0

4.5

10

3.6

Unknown

0

0

11.3

10.7

78.1

0

3.8

60.7

0

22.7

57.5

3.6

Hydrolyzed

3.1

0

1.3

10.7

Immune-modulating, hydrolyzed

3.1

50

8.8

0

Mixed formula

9.4

13.6

6.3

7.1

Unknown

6.3

13.6

22.5

17.9

Before 48 hours

71.9

36.4

13.8

28.6

After 48 hours

21.9

31.8

55

50

Never fed enterally

6.3

31.8

27.5

17.9

0

0

3.8

3.6

Feeding Tube Placement (%)
Gastric

Enteral Formula (%)
Standard
Immune-modulating

Initiation of Feeding (%)

Unknown
ICU – intensive care unit
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The enteral feeding characteristics of the population by VAE status are shown in
Table 6. Gastric and small bowel tube placement was similar between patients with and
without a VAE. An immune-modulating or hydrolyzed formula was prescribed more
frequently for patients who were not diagnosed with a VAE vs. those diagnosed. A
greater number of non-VAE patients were fed before 48 hours than VAE patients (28 vs.
22, respectively). Similarly, more VAE patients were never fed enterally than non-VAE
patients (21 vs. 15, respectively). However, these differences were not statistically
significant.
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Table 6. Enteral feeding characteristics of the population by VAE status
VAE

Non-VAE

(n = 81)

(n = 81)

Gastric

72

68

Small bowel

4

5

No tube/Unknown

5

8

Standard

20

25

Immune-modulating

20

32

Hydrolyzed

1

4

Immune-modulating, hydrolyzed

10

9

Mixed formula

9

4

No formula/Unknown

21

7

Before 48 hours

22

28

After 48 hours

38

34

Never fed enterally

21

15

Unknown

0

4

P-value

Tube Placement (n)
0.685

Enteral Formula (n)
0.223

Feeding Initiation (n)
0.398

VAE – ventilator associated event
After subdividing by ICU location, 12 of 14 patients (86%) in the MICU who
were diagnosed with a VAE were either never fed enterally or fed >48 hours after
admission vs. 7 of 13 (54%) patients in the MICU who were not diagnosed with a VAE
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(p=0.031). No other relationships between the type of feeding initiation, tube placement,
or enteral formula were found by VAE status for the population or by ICU location
(Tables 7-10).
Table 7. Enteral feeding characteristics by VAE status in patients admitted to the Neuro
ICU
VAE

Non-VAE

(n=16)

(n=16)

Gastric

16

16

Small bowel

0

0

Standard

11

14

Immune-modulating

0

0

Hydrolyzed

0

1

Immune-modulating, hydrolyzed

0

1

Mixed formula

3

0

No formula/Unknown

2

0

Before 48 hours

10

13

After 48 hours

4

3

Never fed enterally

2

0

P-value

Tube Placement (n)
N/Aa

Enteral Formula (n)
0.154

Feeding Initiation (n)

a

No statistics are computed because tube placement is a constant

ICU – intensive care unit
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Table 8. Enteral feeding characteristics by VAE status in patients admitted to the Burn
ICU
VAE

Non-VAE

(n=11)

(n=11)

Gastric

11

10

Small bowel

0

0

Unknown/no tube

0

1

Standard

0

0

Immune-modulating

3

2

Hydrolyzed

0

0

Immune-modulating, hydrolyzed

5

6

Mixed formula

1

2

Unknown/No formula

2

1

Before 48 hours

4

4

After 48 hours

5

2

Never fed enterally

2

5

P-value

Tube Placement (n)
N/Aa

Enteral Formula (n)
0.751

Feeding Initiation (n)

a

No statistics are computed because tube placement is a constant

ICU – intensive care unit
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Table 9. Enteral feeding characteristics by VAE status in patients admitted to the Surgical
ICU
VAE

Non-VAE

(n=40)

(n=40)

Gastric

34

29

Small bowel

3

5

Unknown/No Tube

3

6

2

1

Immune-modulating

17

29

Hydrolyzed

0

1

Immune-modulating, hydrolyzed

5

2

Mixed formula

4

1

Unknown/No tube

12

6

Before 48 hours

6

5

After 48 hours

22

22

Never fed enterally

12

10

Unknown

0

3

P-value

Tube Placement (n)
0.380

Enteral Formula (n)
Standard

0.134

Feeding Initiation (n)

ICU – intensive care unit

	
  

0.925
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Table 10. Enteral feeding characteristics by VAE status in patients admitted to the
Medical ICU
VAE

Non-VAE

(n = 14)

(n = 14)

Gastric

11

13

Small bowel

1

0

Unknown

2

1

Standard

7

10

Immune-modulating

0

1

Hydrolyzed

1

2

Immune-modulating, hydrolyzed

0

0

Mixed formula

1

1

Unknown/ No formula

5

0

Before 48 hours

2

6

After 48 hours

7

7

Never fed enterally

5

0

Unknown

0

1

P-value

Tube Placement (n)
0.288

Enteral Formula (n)
0.846

Feeding Initiation (n)

ICU – intensive care unit

	
  

0.031

	
  
	
  

CHAPTER V
Discussion and Conclusions
Patients admitted to an ICU at Grady Memorial Hospital who were mechanically
ventilated for >48 hours and who received a feeding tube were more likely to be fed an
immune-modulating formula into their stomach. Most patients were fed >48 hours after
admission. We found an association between the lack of initiation of enteral nutrition and
diagnosis of a VAE in Medical ICU patients but not in any other ICU population. We
found no association between feeding tube placement or the type of enteral formula used
and VAE status in the total population or after subdivision by ICU location.
Current clinical guidelines recommend that enteral nutrition be started within 24
to 48 hours of admission.3,12 Artinian et al. (2006) found that early feeding was
associated with a higher risk of VAP development. We did not find that early feeding
was associated with a VAE. However, Artinian et al. defined early feeding as feeding
within 48 hours of mechanical ventilation in patients who were ventilated for more than 2
days and included patients that were not ventilated upon admission. In our study, patients
were defined as having been fed early if they were fed within 24 to 48 hours of
mechanical ventilation but patients had to be mechanically ventilated upon admission. In
the Artininan et al. study, patients were not excluded if they were not intubated on
admission. Therefore, patients may have received food prior to ventilation, which may
have contributed to their findings. Moreover, researchers from the study speculate that
their patient population was less ill suggesting that they may have been fed prior to
mechanical ventilation and possibly aspirated their food. Our study excluded patients that
24	
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could feed independently and thus eliminated this possibility. In contrast, patients in our
population who were admitted to the MICU and never fed using the gastrointestinal tract
were more likely to have been diagnosed with a VAE.
Altintas et al. (2011) conducted a study that examined the effect of enteral vs.
parenteral nutrition (PN) on outcomes of mechanically ventilated patients.13 The primary
outcome was the development of VAP. This study was a randomized control trial where
nutrition support was started within 48 hours on 71 patients. Thirty patients were
randomized to enteral feedings and the remaining 41 patients received PN. The
researchers did not find that PN increased the risk of VAP in the medical-surgical ICU.
While not statistically significant, 26.8% of the patients who received PN developed VAP
compared to 16.7% of patients who received enteral nutrition. Our study did find a
significant association between not receiving enteral nutrition with the diagnosis of a
VAE in the MICU. This could be because the patients in the category of ‘never fed
enterally’ included patients that received PN as well as those who received no nutrition.
This association could also be present because the patients admitted to the MICU were
more critically ill than the patients admitted to other ICUs. The MICU could have a
disproportionate number of patients with malnutrition due to the presence of chronic
disease, which means they could have impaired immune function as well as bacterial
translocation from the gastrointestinal tract. The patient’s malnutrition is then
exacerbated once they are admitted with an acute illness and are not fed through the
gastrointestinal tract.
Our results were similar to those of Capparos et al. (2001) with regard to the type
of enteral formula prescribed. Approximately 60% of patients in the study received
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either a standard formula or an immune-modulating formula. Capparos et al. did not find
a significant relationship between the type of enteral formula and nosocomial infection,
which includes VAP. However, the only two formulas used in the study were a standard
high-protein formula and an immune-modulating formula. Our study also did not find a
relationship between type of formula and VAE. Therefore, the type of enteral formula
may not be as important as receiving optimal nutrition. Optimal nutrition is defined as
meeting energy expenditure as assessed by indirect calorimetry as well as protein intake
of 1.2 g/kg of preadmission weight for critically ill patients.14 When a patient receives
optimal nutrition there is a protection and a rebuilding of body protein mass. Inadequate
nutrition is associated with an increased risk of complications such as infection.14 Given
that no association between the type of formula prescribed and the development of a
VAE was found in our study, it is possible that providing adequate calories and protein
plays a greater role in the relationship. Nutritional requirements were not determined as a
part of our study but would be important to evaluate in future research.
The findings of this study regarding enteral tube placement and VAE association
are consistent with the findings of White et al. (2009) and Davies et al. (2012). These
studies did not find an association between VAP and feeding tube placement. However,
Acosta-Escribano et al. (2010) and Hsu et al. (2009) found that patients fed into the small
bowel had a lower incidence rate of VAP. Acosta-Escribano et al. examined feeding tube
placement only in traumatic brain injury (TBI) patients. While some of the patients in our
study had experienced TBI, this was not the primary diagnosis in the majority of the
population. TBI patients are at increased risk for gastroparesis lasting 3-5 days, which
increases risk for aspiration and which will sometimes necessitate a post-pyloric tube
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placement.15 Hsu et al. found that patients in the MICU had a lower incidence rate of
VAP if they were fed into the small bowel. While the current study did not have similar
findings, it is important to note that the majority of patients (86.4%), regardless of ICU,
received a gastric tube placement. This did not allow for a true analysis on effectiveness
of small bowel tube feedings on the incidence of VAE.
The primary limitation of our study is that it is retrospective. We are unable to
make a determination of cause and effect between VAE and lack of feeding in the
medical ICU. Furthermore, we are unable to fully evaluate the effect of gastric vs. small
bowel feeding tube placement and enteral formula type since there were few patients who
received a small bowel tube or formulas other than standard or immune modulating. After
subdividing by ICU location, this became more problematic as there were insufficient
numbers of patients to make the comparison and little diversity in terms of feeding tube
placement and the type of formula used. Also, some patients’ height, weight and
calculated BMI were estimated. Therefore, these results should be interpreted with
caution. Future research should include analysis of VAE status by BMI category
(underweight, normal weight, overweight, or obese). Another limitation of the study is
that patients were excluded if they were intubated after 24 hours of admission. Since we
did not capture the patients that were intubated later, our results cannot be generalized to
all ICU patients who are mechanically ventilated. However, by eliminating these patients,
food consumed orally was not introduced and thus was not a confounding factor in the
evaluation of the association between the timing of implementation, enteral formula, or
feeding tube placement and a VAE. Another limitation is that nutrition intake was not
compared to the patients’ calorie and protein requirements. Our results may reflect
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inadequate nutrition vs. the effect of feeding initiation on the development of a VAE.
Despite the limitations of our study, adults admitted to the MICU may have a
reduced risk of developing a VAE if fed within 48 hours of admission. The type of
enteral formula provided and the route of administration were not associated with the
diagnosis of VAE. It is understandable that patients, under certain circumstances (e.g.,
abdominal surgery or being hemodynamically unstable), cannot be fed enterally while
being mechanically ventilated. If patients in the MICU cannot be fed, the healthcare
team should take extra precautions to reduce the risk of the patient having a VAE. These
precautions include elevating the head of the bed, oral care with chlorhexidine, stress
ulcer prophylaxis, deep venous thrombosis prophylaxis, daily assessment of sedation and
spontaneous breathing, improving secretion drainage by body positioning, leakage
prevention through endotracheal tube modifications, and inhibition of biofilm formation.1
Increased awareness and preparedness with these patients can help to decrease the risk of
VAE in the MICU population and improve outcomes.
Future studies should include a prospective evaluation of all critical care patients
to further evaluate the effect of nutrition on VAE outcome. In order to further understand
the relationship between VAE and lack of feeding in the MICU, future randomized
studies need to be performed in order to determine a cause and effect relationship
between feeding initiation and VAE. There should be future prospective randomized
trials including all critical care patients in order to effectively evaluate small bowel vs.
gastric feeding and the type of enteral formula prescribed. Future research should also
include studies that match VAE and non-VAE patients by diagnosis and age.
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